54gene valuation slashed by over $100M amid job cuts and CEO exit

It’s been a strange couple of months at African genomics startup 54gene. In August, it sacked 95 employees, mostly contract staff (in labs and sales departments) hired to work in 54gene’s COVID business line launched in 2020. In September, co-founder and VP of Engineering Ogochukwu Francis Osifo left the company. And this week, founder and now ex-CEO Dr. Abasi Ene-Obong stepped down from his executive role to be replaced by General Counsel Teresia L. Bost. 
This news coincided with more job cuts. The company confirmed to TechCrunch that this second round of layoffs, which took place on Tuesday

リンク元